BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15139499)

  • 1. Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.
    Manolakopoulos S; Bethanis S; Armonis A; Economou M; Avgerinos A; Tzourmakliotis D
    Dig Dis Sci; 2004 Mar; 49(3):462-5. PubMed ID: 15139499
    [No Abstract]   [Full Text] [Related]  

  • 2. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
    Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
    Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications of antiandrogens in benign hyperplasia of the prostate].
    Benassayag E
    J Urol (Paris); 1995; 101(2):109-10. PubMed ID: 8522854
    [No Abstract]   [Full Text] [Related]  

  • 4. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system.
    Manso G; Thole Z; Salgueiro E; Revuelta P; Hidalgo A
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):253-9. PubMed ID: 16294367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe acute hepatitis due to flutamide and elevated CA 19.9].
    Ramírez R; Ruiz MA; Auguet T; Richart C
    Gastroenterol Hepatol; 2005; 28(7):433. PubMed ID: 16137480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute flutamide-induced hepatitis].
    Nicolás D; Pérez-EbrI ML; Sarrión JV; Nos P
    Gastroenterol Hepatol; 1999 May; 22(5):262-3. PubMed ID: 10396113
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe hepatitis and liver failure induced by cyproterone acetate.
    Murphy BJ; Collins BJ
    Aust N Z J Med; 1996 Oct; 26(5):724. PubMed ID: 8958378
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toxic hepatitis after flutamide treatment].
    Bengoechea Gallastegui L; Vita Garay A; Castiella Eguzkiza A; Egido Arroyo JF
    Aten Primaria; 2005 Jun; 36(2):112. PubMed ID: 15989835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal fulminant hepatic failure due to cyproterone acetate.
    Friedman G; Lamoureux E; Sherker AH
    Dig Dis Sci; 1999 Jul; 44(7):1362-3. PubMed ID: 10489919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant hepatic failure associated with bicalutamide.
    Schellhammer PF
    Urology; 1997 Nov; 50(5):827. PubMed ID: 9372905
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of fulminant hepatitis caused by antiandrogen, flutamide in a patient with prostate cancer].
    Satoh T; Egawa S; Katsuta M; Iwamura M; Uchida T; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1997 Jul; 88(7):694-6. PubMed ID: 9267134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxic hepatitis caused by flutamide and hirsutism].
    Román Llorente FJ; Alvarez Navascués C; Suárez González A; González Bernal AC
    Gastroenterol Hepatol; 2000 May; 23(5):258. PubMed ID: 10902281
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiandrogen hepatotoxicity in patients with chronic viral hepatitis.
    Pu YS; Liu CM; Kao JH; Chen J; Lai MK
    Eur Urol; 1999 Oct; 36(4):293-7. PubMed ID: 10473987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flutamide-induced acute hepatitis in advanced prostate cancer patients.
    Kraus I; Vitezic D; Oguic R
    Int J Clin Pharmacol Ther; 2001 Sep; 39(9):395-9. PubMed ID: 11563686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed drug eruption caused by cyproterone acetate.
    Galindo PA; Borja J; Feo F; Gómez E; Chamorro R; Encinas C; García R
    Allergy; 1998 Aug; 53(8):813. PubMed ID: 9722234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute cholestatic hepatitis secondary to flutamide].
    Mena FJ; Goyeneche ML; Velicia R; González JM; Bellido J; Caro-Patón A
    Rev Esp Enferm Dig; 1998 May; 90(5):376-7. PubMed ID: 9656761
    [No Abstract]   [Full Text] [Related]  

  • 17. Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.
    Rosenthal SA; Linstadt DE; Leibenhaut MH; Andras EJ; Brooks CP; Stickney DR; Chang GC; Wolkov HB; Gilbert RM
    Radiology; 1996 May; 199(2):451-5. PubMed ID: 8668793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should cyproterone acetate be removed from our prescriptions?].
    Plu-Bureau G
    Gynecol Obstet Fertil Senol; 2019 Dec; 47(12):823-824. PubMed ID: 31634588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fulminant hepatitis associated with treatment with flutamide].
    García-Gascó P; Morata Aldea C; Segura Huertas A; Aparicio Urtasun J
    Med Clin (Barc); 1997 Dec; 109(20):820. PubMed ID: 9493166
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyproterone acetate in paraphilia.
    Panesar N; Allard B; Pai N; Valachova I
    Aust N Z J Psychiatry; 2011 May; 45(5):428. PubMed ID: 21417675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.